Search Results - "Choi, Beom K"
-
1
Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis
Published in eLife (24-12-2019)“…Lymph nodes (LNs) are a common site of metastasis in solid cancers, and cutaneous melanomas show inherent properties of LN colonization. However, interactions…”
Get full text
Journal Article -
2
4-1BB immunotherapy: advances and hurdles
Published in Experimental & molecular medicine (01-02-2024)“…Since its initial description 35 years ago as an inducible molecule expressed in cytotoxic and helper T cells, 4-1BB has emerged as a crucial receptor in…”
Get full text
Journal Article -
3
The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
Published in Frontiers in immunology (10-12-2020)“…CD137, a member of the TNFR family, is a costimulatory receptor, and CD137L, a member of the TNF family, is its ligand. Studies using CD137- and…”
Get full text
Journal Article -
4
TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma
Published in Molecules and cells (30-11-2021)“…Leiomyosarcoma (LMS) is a mesenchymal malignancy with a complex karyotype. Despite accumulated evidence, the factors contributing to the development of LMS are…”
Get full text
Journal Article -
5
Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer
Published in Cancers (24-08-2020)“…Hypoxia-inducible factors (HIFs) induced by reduced O2 availability activate the transcription of target genes encoding proteins that play important roles in…”
Get full text
Journal Article -
6
Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells
Published in Nature communications (07-09-2021)“…Adoptive T cell therapy (ACT) requires lymphodepletion preconditioning to eliminate immune-suppressive elements and enable efficient engraftment of adoptively…”
Get full text
Journal Article -
7
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
Published in Nature communications (01-02-2018)“…Chimeric antigen receptor (CAR) T cell therapy is an effective method for treating specific cancers. CARs are normally designed to recognize antigens, which…”
Get full text
Journal Article -
8
Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses
Published in International journal of molecular sciences (01-09-2023)“…The interaction between regulatory T (Treg) cells and self-reactive T cells is a crucial mechanism for maintaining immune tolerance. In this study, we…”
Get full text
Journal Article -
9
Targeting Actomyosin Contractility Suppresses Malignant Phenotypes of Acute Myeloid Leukemia Cells
Published in International journal of molecular sciences (14-05-2020)“…Actomyosin-mediated contractility is required for the majority of force-driven cellular events such as cell division, adhesion, and migration. Under…”
Get full text
Journal Article -
10
Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy
Published in Autophagy (01-09-2016)“…VSIG4/CRIg (V-set and immunoglobulin domain containing 4) is a transmembrane receptor of the immunoglobulin superfamily that is expressed specifically on…”
Get full text
Journal Article -
11
4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling
Published in PloS one (11-05-2015)“…4-1BB (CD137), a member of the tumor necrosis factor receptor superfamily (TNFRSF), is primarily expressed on activated T cells and is known to enhance…”
Get full text
Journal Article -
12
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study
Published in Frontiers in immunology (08-11-2021)“…Interleukin-13 receptor α 2 (IL13Rα2) is a promising tumor-directed antigen of malignant glioma (MG). Here, we examine the efficacy and safety of T cells…”
Get full text
Journal Article -
13
4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells
Published in PloS one (11-07-2013)“…4-1BB (CD137), an inducible costimulatory molecule, strongly enhances the proliferation and effector function of CD8(+) T cells. Since the serine/threonine…”
Get full text
Journal Article -
14
Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice
Published in Cells (Basel, Switzerland) (02-12-2022)“…In adoptive T cell therapy (ACT), the transfer of tumor-specific T cells is paralleled by the conditioning regimen to increase therapeutic efficacy…”
Get full text
Journal Article -
15
The repopulating cancer cells in melanoma are characterized by increased mitochondrial membrane potential
Published in Cancer letters (28-11-2016)“…Highlights • B16-F10 melanoma cells have mitochondrial heterogeneity under stress conditions. • B16-F10 melanoma cells with enhanced mitochondrial membrane…”
Get full text
Journal Article -
16
TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma
Published in Molecules and cells (2021)“…Leiomyosarcoma (LMS) is a mesenchymal malignancy with a complex karyotype. Despite accumulated evidence, the factors contributing to the development of LMS are…”
Get full text
Journal Article -
17
IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model
Published in Cells (Basel, Switzerland) (07-08-2021)“…Adoptive cell therapy (ACT) using tumor-reactive T cells is a promising form of immunotherapy to specifically target cancer. However, the survival and…”
Get full text
Journal Article -
18
4-1BB Functions As a Survival Factor in Dendritic Cells
Published in The Journal of immunology (1950) (01-04-2009)“…4-1BB (CD137) is expressed on dendritic cells (DCs) and its biological function has remained largely unresolved. By comparing 4-1BB-intact (4-1BB(+/+)) and…”
Get full text
Journal Article -
19
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells
Published in Journal of leukocyte biology (01-05-2004)“…4‐1BB (CD137) is a costimulatory molecule involved in the activation and survival of CD4, CD8, and natural killer cells. Although a great deal has been learned…”
Get full text
Journal Article -
20
Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Published in Molecular cancer therapeutics (01-02-2009)“…Chemotherapy can precondition for immunotherapy by creating an environment for homeostatic lymphoproliferation and eliminating some of the suppressive immune…”
Get full text
Journal Article